Test description
Testing for germline variants within the MMR genes (MLH1, MSH2, MSH6 and PMS2) or the EPCAM gene.
Test information
Test name
BRAoVOTM Lynch Gene panel
Clinical indication
Used for investigation of Lynch Syndrome in patients with colorectal cancer or endometrial cancer where there is a familial risk of ≥10%.
Gene(s)
MLH1, MSH2, MSH6, PMS2, EPCAM
Method
Massively Parallel Sequencing
Turn around time
4 - 5 weeks
Medicare eligibility
73354 – conditions apply
Price
$499 if not Medicare eligible
Test request form
Cancer Genetics request form preferred. Standard pathology request form accepted.
Sample type
Blood x 2
Collection type
EDTA
Special instructions
2 x Bloods taken at 10 minute intervals. Pre-test genetic counselling required. Patient to provide consent prior to testing.
FAQ
No items found.
Resources
No items found.